Skip to main content
Wolfson Institute of Population Health
  1. WIPH
  2. People
  3. Profiles

Professor Alastair Noyce, BMedSci, MB BS, MSc, MRCP, PhD, FHEA

Alastair

Professor in Neurology and Neuroepidemiology and Consultant Neurologist

Email: a.noyce@qmul.ac.uk

Profile

I am a Professor in Neurology and Neuroepidemiology in the Centre for Preventive Neurology (CPN), in the Wolfson Institute of Population Health, Queen Mary University of London (QMUL). I am the deputy lead for the CPN and a Consultant Neurologist at Barts Health NHS Trust.

I graduated from Barts and the London (QMUL) in 2007 and I pursued integrated training via the Foundation Academic Programme and an NIHR Academic Clinical Fellowship at UCL. Between 2012-2016 I undertook a PhD in Neuroscience at UCL and between 2014-2016 I undertook an MSc in Epidemiology at London School of Hygiene and Tropical Medicine. I re-joined QMUL and the PNU in 2017 to lead the Parkinson’s programme of work.

My research interests are Parkinson’s disease and other neurodegenerative disorders, particularly early identification and epidemiological aspects, including environmental, clinical and genetic determinants. I am the co-principal investigator of the PREDICT-PD study, principal investigator for the East London Parkinson’s Disease project and chief investigator for the Access-PD study.

I am a member of the International Parkinson and Movement Disorder Society (MDS). I graduated from the MDS LEAP leadership programme in 2020, and then became a member of the faculty for the LEAP, teaching leadership skills to early career movement disorders specialists around the world. I am the Chair of the MDS Epidemiology Study Group, a member of the MDS Early Onset PD Study Group and the Equality of Access to Care Committee. I on the Global Parkinson’s Genetics Program (GP2) and lead two of its working groups, focusing on Training and Networking and Prodromal PD. I am Associate Editor for the Journal of Parkinson’s Disease.

Away from neurodegenerative disease, I am interested in the emerging link between recreational use of nitrous oxide (laughing gas) and neurological harm. I have led the drafting of national guidance for managing the range of neurological conditions associated with nitrous oxide, as well as describing the clinical manifestations in patients in order to raise awareness amongst healthcare workers.

 

Research

Research Interests:

Neurology

Epidemiology

Genetics

Predictive models

Clinical research

Publications

  • Jacobs BM, Schalk L, Tregaskis-Daniels E et al. (2026). Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds. nameOfConference


  • Kouchache T, Zolfaghari S, Bouhadoun S et al. (2026). Reply to Comment on “Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease”. nameOfConference


    QMRO: qmroHref
  • Lüth T, Laabs B, Sendel S et al. (2026). The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin. nameOfConference


    QMRO: qmroHref
  • Torricelli R, Kenny JE, Bache E et al. (2026). Handwriting patterns in isolated rapid eye movement sleep behaviour disorder.. nameOfConference


  • Okubadejo NU, Schaeffer E, Noyce AJ et al. (2026). Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score. nameOfConference


    QMRO: qmroHref
  • Smith LJ, Jeyaganesh J, Li X et al. (2026). The Use of a Digital Social Forum in a Parkinson’s Disease Risk Cohort: A Thematic Analysis of Forum Messages. nameOfConference


  • Tolosa E, Poewe W, Noyce AJ et al. (2026). Towards biomarker-based diagnosis of Parkinson disease. nameOfConference


  • Kenny J, Torricelli R, Zirra A et al. (2026). A cross-sectional exploration of the relationship between Parkinson's disease and peripheral blood immune cells in an ethnically diverse East London population. nameOfConference


    QMRO: qmroHref
  • Bramich S, Lam A, King AE et al. (2026). Circadian dysregulation in probable isolated REM sleep behaviour disorder: actigraphy insights from the Tasmanian ISLAND Sleep Study. nameOfConference


    QMRO: qmroHref
  • Bramich S, Noyce A, King AE et al. (2026). Remote unsupervised tests of isolated REM sleep behaviour disorder in the community: results from the Tasmanian ISLAND Sleep Study. nameOfConference


View profile publication page

Supervision

Jonggeol Kim, Global Parkinson's Genetics Programme, Genetic Determinants of Parkinson's Disease

Benjamin Jacobs (subsidiary supervisor), MRC, Genetic Association study in individuals of Diverse Ancestral backgrounds with Multiple Sclerosis (ADAMS)

Alex Zirra, The Medical College of St Bartholomew’s Hospital Trust, Cognitive features of Parkinson’s disease in a diverse population

Ellen Camboe, Barts Charity, Parkinson’s Disease Psychosis in a Diverse Population

Harneek Chohan, Early clinical and biological markers in Parkinson's Disease

Back to top